Galectin Therapeutics (GALT)
(Delayed Data from NSDQ)
$2.65 USD
+0.02 (0.76%)
Updated Sep 26, 2024 03:59 PM ET
After-Market: $2.65 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/11/24 |
---|---|
Current Quarter | -0.20 |
EPS Last Quarter | -0.20 |
Last EPS Surprise | -25.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.79 |
Next Year | -1.68 |
EPS (TTM) | -0.79 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 36.32M |
# of Estimates | NA | NA | NA | 1 |
High Estimate | NA | NA | NA | 36.32M |
Low Estimate | NA | NA | NA | 36.32M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.20 | -0.21 | -0.79 | -1.68 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.20 | -0.21 | -0.79 | -1.68 |
High Estimate | -0.20 | -0.21 | -0.79 | -1.68 |
Low Estimate | -0.20 | -0.21 | -0.79 | -1.68 |
Year ago EPS | -0.24 | -0.16 | -0.74 | -0.79 |
Year over Year Growth Est. | 16.67% | -31.25% | -6.76% | -112.66% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.20 | -0.21 | -0.79 | -1.68 |
7 Days Ago | -0.20 | -0.21 | -0.79 | -1.68 |
30 Days Ago | -0.20 | -0.21 | -0.79 | -1.68 |
60 Days Ago | -0.17 | -0.17 | -0.66 | -1.59 |
90 Days Ago | -0.17 | -0.17 | -0.66 | -1.59 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.20 | -0.21 | -0.79 | -1.68 |
Zacks Consensus Estimate | -0.20 | -0.21 | -0.79 | -1.68 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.20 | -0.19 | -0.16 | -0.24 | NA |
Estimate | -0.16 | -0.16 | -0.16 | -0.16 | NA |
Difference | -0.04 | -0.03 | 0.00 | -0.08 | -0.04 |
Surprise | -25.00% | -18.75% | 0.00% | -50.00% | -23.44% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more